Mivebresib (ABBV-075) is a potent and orally active bromodomain and extraterminal domain (BET) bromodomain inhibitor. Mivebresib binds to BRD4 with a Ki of 1.5 nM[1].
Molecular Weight:
459.47
Purity:
99.69
CAS Number:
[1445993-26-9]
Formula:
C22H19F2N3O4S
Target:
Apoptosis,Epigenetic Reader Domain
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted